Follicular lymphoma trials in Netherlands

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

  Where

  Groningen, Nijmegen, Rotterdam, Utrecht

  Age

  18 years and over

  People

  572 worldwide

  Run by

  Nurix Therapeutics, Inc.

  See details and how to joinNCT05131022 · EU 2023-510541-25-00
• Phase 2Taking people
  Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients

  Where

  Amsterdam, Groningen, Leiden, Rotterdam

  Age

  18 years to 70 years

  People

  213 worldwide

  Run by

  Miltenyi Biomedicine GmbH

  See details and how to joinNCT04844866 · EU 2023-506270-13-00
• Phase 3Taking people
  A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

  Where

  Amsterdam, Groningen, Utrecht

  Age

  18 years and over

  People

  400 worldwide

  Run by

  Celgene

  See details and how to joinNCT06911502 · EU 2024-519152-82-00